Erratum to “Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study”

ESMO Open 2026 Open access

Read full text
Authors: F. Schettini, F. Brasó-Maristany, T. Pascual, N. Lorman-Carbó, S. Nucera, M Bergamino, P. Galván, B. Conte, E. Seguí, I. Garcia Fructuoso, R. Gómez Bravo, A.B. Rodríguez
+16 more O. Martínez-Sáez, N. Chic, M. Vidal, B. Adamo, B. González-Farre, E. Sanfeliu, I. Cebrecos, E. Mension, G. Oses, Mariavittoria Locci, M. Mollà, S. Ganau, P. Jares, S Vidal-Sicart, M. Muñoz, A. Prat
DOI: 10.1016/j.esmoop.2025.105328
Cited by: 0

Fields of Study & Subjects

Breast Cancer Treatment Studies HER2/EGFR in Cancer Research Advanced Breast Cancer Therapies

Publication details

Journal / source
ESMO Open
Volume
11
Issue
1
Pages
105328–105328
Publication date
1 January 2026
Language
EN